Pharmacokinetics of the novel anticonvulsant hepp after single intravenous administration of three different doses in dogs-Reference-Cited by-同舟云学术

Pharmacokinetics of the novel anticonvulsant hepp after single intravenous administration of three different doses in dogs

Published:1995-03 Issue:2 Volume:16 Page:105-112
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Gómez M. Lisbeth E.,Lehmann F. Pedro A.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference13 articles.

1. Dose-dependent pharmacokinetics: Experimental observations and theoretical considerations

2. The GABA-withdrawal syndrome: a new model of focal epileptogenesis

3. , and , Effects of HEPP on a new model of focal status epilepticus: the GABA-withdrawal syndrome. Proceedings of the Symposium on New Anticonvulsant Drugs Synthesized in Mexico, Colima, May 1990.

4. , and , Pharmacokinetics of D, L-3-hydroxy-3-ethyl-3-phenylpropionamide (HEPP) in rabbits following single and multiple doses. In preparation.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gestational Age Dependency in the Prenatal Toxicity and in the Disposition Kinetics of the Novel Anticonvulsant HEPP (D,L-3-Hydroxy-3-ethyl-3-phenylpropionamide) after Subcutaneous Administration in Pregnant Rats;International Journal of Toxicology;2007-05

2. Pharmacokinetics of HEPP, a new anticonvulsant, in healthy subjects and rabbits after multiple doses;Biopharmaceutics & Drug Disposition;2004-02-05

3. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits;Biopharmaceutics & Drug Disposition;2003-05-23

4. Pharmacokinetics of ?,?-3-hydroxy-3-ethyl-3-phenylpropionamide (HEPP) in pregnant rats at different stages of gestation and maternal–fetal disposition during late pregnancy;Reproductive Toxicology;2003-04

5. Pharmacokinetic Interaction in Rabbits between a New Anticonvulsant, DL-3-Hydroxy-3-ethyl-3-phenylpropionamide, and Phenytoin;Journal of Pharmacy and Pharmacology;1998-12